The Safety of Oral Ketoconazole in the Treatment of Skin Diseases (Single Blinded, Therapeutic, Comparative Study)

Journals Menu

Follow SCIRP

ISSN Print: 2161-4105
ISSN Online: 2161-4512
www.scirp.org/journal/jcdsa
E-mail: jcdsa@scirp.org

"The Safety of Oral Ketoconazole in the Treatment of Skin Diseases (Single Blinded, Therapeutic, Comparative Study)"
written by Khalifa E. Sharquie, Adil A. Noaimi, Wasnaa S. Al-Salam,
published by Journal of Cosmetics, Dermatological Sciences and Applications, Vol.8 No.4, 2018

has been cited by the following article(s):

[1]	Triple therapy for acute and chronic cutaneous leishmaniasis using oral zinc sulfate, oral ketoconazole and topical podophyllin: Triple therapy for cutaneous …
	Journal of Pakistan Association of …, 2022

[2]	New multiple therapy of resistant and relapsing dermatophyte infections during epidemic status
	Journal of Pakistan Association of …, 2022

[3]	Antifungal effectiveness test fragrant leaf ethanol extract (Pandanus Amaryllifolium Robx) against fungus Pityrosporum Ovale in vitro
	ITEGAM-JETIA, 2021

[4]	Preparation of Ketoconazole Liposomes with an Ultrasonic and an Injection Method Using Vegetable Oils
	2020

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top

[1]	Leishmania Recidivans Could Be Induced by Intralesional Infiltration of Cutaneous Leishmaniasis by Sodium Stibogluconate, with New Therapeutic Trial Journal of Clinical and Experimental Investigations, 2022 DOI:10.29333/jcei/11516